Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
NCT06360380
This study is recruiting at 8 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
The REFORM-HF study aims to test a new technology, AQUAPASS, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure. Patients will wear a lightweight suit that helps remove excess fluids through their sweat. The investigators want to see if the AQUAPASS system can remove an additional 500mL of fluids during treatment, alongside patients' regular medications like diuretics. Participants will be treated in the hospital or in the outpatient clinic.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Chronic Heart Failure
- CKD Stage 3
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 21 to 79 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- AquaPass Medical Ltd.
- Last updated on ClinicalTrials.gov
- July 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- UC San Diego Health-Sulpizio Cardiovascular Center · La Jolla, CA
- UC San Francisco · San Francisco, CA
Minnesota · 1
- University of Minnesota · Minneapolis, MN
New York · 2
- Northwell Health- Lenox Hill Hospital · New York, NY
- Rochester Regional Health · Rochester, NY
North Carolina · 2
- Mission Hospital · Asheville, NC
- Cone Health Advanced Heart Failure Clinic at Moses Cone · Greensboro, NC
Texas · 1
- Austin Heart Hospital · Austin, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.